1. Zogenix, Inc. (ZGNX): Engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. Market cap of $64.64M. Net insider shares purchased over the last six months at 7.16M, which is 18.64% of the company's 38.38M share float.